The recognition and remodeling of amyloidogenic protein species involves a sequential conformational templating mechanism mediated by HSP90-HSP70 heterocomplexes, where HSP90 serves as the primary conformational sensor while HSP70 provides the refolding machinery. This mechanism centers on HSP90's unique ability to bind partially folded client proteins through its middle domain, which recognizes the altered global fold topology that occurs when amyloidogenic segments become exposed. Upon HSP90 b
DNAJB6, DNAJB2, HSPA8, HSPA1A · protein biochemistry · -
Composite 0.000
Price $0.00
Evidence For 0
Evidence Against 0
The J-protein co-chaperone system operates through a novel ATP-independent disaggregation mechanism that localizes pathogenic protein recognition to specific membrane compartments. Rather than relying on HSP70 ATPase cycling, DNAJB6 and DNAJB2 form constitutively active membrane-associated complexes at the endoplasmic reticulum and mitochondrial surfaces through direct lipid interactions via their amphipathic helices. DNAJB6's S/T-rich domain contains cryptic membrane-binding motifs that become
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
# Critical Evaluation of Chaperone Selectivity Hypotheses
## Hypothesis 1: Co-chaperone Heterogeneity (DNAJB6/DNAJB2)
**Weak Links:**
- The "client code" is descriptive terminology lacking mechanist...
Domain Expert
# Feasibility Assessment: Chaperone Selectivity Hypotheses
## Executive Summary
Of the five hypotheses, **Hypothesis 3 (amyloidogenic segment recognition)** emerges as most feasible for therapeutic ...
# Critical Evaluation of Chaperone Selectivity Hypotheses
## Hypothesis 1: Co-chaperone Heterogeneity (DNAJB6/DNAJB2)
**Weak Links:**
- The "client code" is descriptive terminology lacking mechanist...
Domain Expert
# Feasibility Assessment: Chaperone Selectivity Hypotheses
## Executive Summary
Of the five hypotheses, **Hypothesis 3 (amyloidogenic segment recognition)** emerges as most feasible for therapeutic ...